CDTX stock

Cidara Therapeutics Inc (CDTX) financials · $6.96B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Cidara Therapeutics Inc (CDTX) $6.96B cap.

Cached income statement (latest stored periods)
LineQ3 2025Q2 2025
RevenueN/AN/A
Operating Income-$88.6M-$27.4M
Net Income-$83.2M-$25.7M
EPS (Diluted)-$3.10-$1.65
Cached balance sheet (latest stored periods)
LineQ3 2025Q2 2025
Total Assets$518.6M$534.3M
Current Assets$442.8M$531.8M
Cash & Equivalents$293.7M$510.6M
PP&E$293.0K$321.0K
Total Liabilities$96.3M$33.2M
Current Liabilities$95.8M$32.3M
Shareholders' Equity$422.4M$501.2M
Retained Earnings-$743.7M-$660.5M
Cached annual cash flow
LineFY2023FY2022
Operating Cash Flow-$8.08M-$35.4M
CapEx$201.0K$100.0K
Investing Cash Flow-$201.0K-$100.0K
Financing Cash Flow$26.0M-$1.72M
Net Change in Cash$17.7M-$37.3M
Free Cash Flow-$8.28M-$35.5M
These statements as JSON? API free 100/day

FAQ

What is CDTX P/E and revenue?

Cidara Therapeutics Inc (CDTX) $6.96B cap.

What is CDTX revenue?

CDTX income-statement cache has no revenue figure yet.

Is CDTX profitable?

Cidara Therapeutics Inc last cached net income is -$83.2M (Q3 2025).

What are CDTX total assets?

Cidara Therapeutics Inc last cached total assets are $518.6M (Q3 2025).

What is CDTX free cash flow?

Cidara Therapeutics Inc last cached free cash flow is -$8.28M (FY2023).

Not investment advice. Cached statements, not a live tape.